Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Berberine on Cardiometabolic Outcomes
Sponsor: University of Central Lancashire
Summary
Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Berberine may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.
Official title: Effects of Berberine Supplementation on Cardiometabolic Parameters
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-07-01
Completion Date
2029-01-01
Last Updated
2026-04-21
Healthy Volunteers
Yes
Conditions
Interventions
Berberine
Berberine supplement 500 mg 2 x per day
Placebo
Placebo control 2 x blinded placebo tablet per day